Workflow
启迪药业(000590.SZ):控股股东变更为湖南赛乐仙

Core Viewpoint - Qidi Pharmaceutical (000590.SZ) has undergone a change in control, with Hunan Sailoxian becoming the controlling shareholder and Jiang Xin as the actual controller [1] Group 1: Corporate Governance Changes - The company held its first extraordinary general meeting on September 22, 2025, where it approved the proposal to supplement the 10th Board of Directors with Jiang Xin and Zhou Yanqi as non-independent directors [1] - On September 23, 2025, the company convened the 7th meeting of the 10th Board of Directors, electing Jiang Xin as the chairman and CEO, and made adjustments to various senior management personnel [1] Group 2: Shareholder and Control Structure - As of the announcement date, the change of control has been completed, with Hunan Sailoxian now as the controlling shareholder [1] - Hunan Sailoxian is committed to maintaining the stable development of the listed company's business and will comply with relevant laws and regulations regarding information disclosure obligations [1]